1037543-19-3

Basic information

• Product Name: N-(2-{[4-(acetylamino)phenyl]carbonylamino}phenyl)-2-aminoacetamide
• Synonyms: N-(2-{[4-(acetylamino)phenyl]carbonylamino}phenyl)-2-aminoacetamide
• CAS NO: 1037543-19-3
• Molecular Weight: 326.355
• Mol File: 1037543-19-3.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: N-(2-{[4-(acetylamino)phenyl]carbonylamino}phenyl)-2-aminoacetamide(CAS DataBase Reference)
• NIST Chemistry Reference: N-(2-{[4-(acetylamino)phenyl]carbonylamino}phenyl)-2-aminoacetamide(1037543-19-3)
• EPA Substance Registry System: N-(2-{[4-(acetylamino)phenyl]carbonylamino}phenyl)-2-aminoacetamide(1037543-19-3)

Safety Data

• Hazardous Substances Data: 1037543-19-3(Hazardous Substances Data)

Upstream product

• 112522-64-2 CI-994 
• 1037543-18-2 N-(2-{[4-(acetylamino)phenyl]carbonylamino}phenyl)-2-[(tert-butoxy)carbonylamino]acetamide 

Downstream Products

• 1037543-20-6 (N-{[N-(2-{[4-(acetylamino)phenyl]carbonylamino}phenyl)-carbamoyl]methyl}carbamoyloxy)methyl(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-enyl)nona-2,4,6,8-tetraenoate 

Relevant articles and documents

MUTUAL PRODRUGS AND METHODS TO TREAT CANCER

Mutual prodrugs comprising retinoids and histone deacetylase inhibitors, methods for production of the mutual prodnigs, and methods of treatment comprising administration of the mutual prodrugs. The retinoids include all-trans retinoic acid, 13-cis retinoic acid, and retinoic acid analogs that have a substitution at C-4. Further, the mutual prodrugs of the present invention can be used as therapeutic agents for the treatment of cancer and dermatological diseases and conditions. Pharmaceutical compositions comprising the mutual prodrugs.